5th Circ. Continues Trend Against 'Innovator Liability'
The Fifth Circuit recently affirmed the dismissal of various claims against manufacturers of the branded drug Reglan and its generic alternative. In Eckhardt v. Qualitest Pharmaceuticals Inc., a three-judge panel joined...To view the full article, register now.
Already a subscriber? Click here to view full article